Report
Martin Arnell
EUR 90.87 For Business Accounts Only

MTG (Hold, TP: SEK85.00) - Pressure on H2 recovery

We have cut our target price to SEK85 (90) and reiterate our HOLD after reducing our 2023e EBITDA by 5% following the soft Q1 report (-11% organic growth YOY). Our updated forecast is slightly below the 2023 guidance of -3% to +2% organic growth YOY and adj. EBITDA margin of 23–25%. In our view, there is still uncertainty around its ability to achieve organic growth and margin improvements in H2 in a still-uncertain market for mobile gaming.
Underlying
Modern Times Group MTG AB Class B

Modern Times Group MTG AB is an entertainment group with operations that include free-television (TV), pay-TV, digital entertainment, radio and content production businesses. Co. has six business segments. Five of these segments, Free-TV Scandinavia, Pay-TV Nordic, Free-TV Emerging Markets, Pay-TV Emerging Markets and CTC Media, comprise Viasat Broadcasting. Co.'s Viasat Broadcasting is a free-TV and pay-TV operator, and also an operator and distributor of live and on-demand streamed free and paid video content over the internet, providing movies, live sports events, TV series, and catch-up services. The sixth business segment mainly comprises Co.'s MTG Studios, MTGx and Radio businesses.

Provider
DnB Markets
DnB Markets

DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.

 

Analysts
Martin Arnell

Other Reports on these Companies
Other Reports from DnB Markets

ResearchPool Subscriptions

Get the most out of your insights

Get in touch